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ABSTRACT
Protected 2'-O-methyl and 2'-O-ethyl ribonucleoside-
3'-O-phosphoramidites were prepared via alkylation of
the ribonucleosides at an early stage in the synthesis.
Utilizing a strategy of minimal protection, the alkylation
was performed with unprotected cytidine and adeno-
sine, or with O6-protected guanosine and N3,5'-O-
protected uridine using methyl or ethyl iodide and
sodium hydride. In subsequent steps, the introduction
of standard protective groups for oligonucleotide
synthesis and the concomitant separation from 3-0-
alkylated isomers was accomplished. A modification of
the phosphitylation procedure permitted facile isolation
of the desired phosphoramidites which show high
coupling efficiencies in oligomer assembly.
INTRODUCTION
2'-O-Methyl oligoribonucleotides are oligonucleotide analogs
which exhibit high resistance to both DNA- and RNA-specific
nucleases and form hybrids of high thermal stability with
complementary RNA (1-7). These analogs, as well as the
recently described 2'-0-allyl oligoribonucleotides (8,9), have
proven to be valuable antisense compounds for studying snRNP-
mediated pre-mRNA splicing and processing (10—15). We have
demonstrated sequence-specific inhibition of hi stone pre-mRNA
processing in vitro using 2'-O-methyl or 2'-O-ethyl
oligoribonucleotide 19mers complementary to the 5'-end of the
U7-snRNP-RNA. These compounds inhibited processing at a
300-fold lower concentration than that required using the
corresponding DNA oligomer (16).
Considerable effort has been directed toward developing
efficient alkylation reactions that yield 2'-O-alkylribonucleoside
building blocks suitable for oligonucleotide assembly. Various
alkylating agents such as dimethylsulfate (17), organostannous
compounds (18), trimethylsulfoniumhydroxide (19,20) and most
commonly diazomethane (21-25) have been used. To synthesize
pyrimidine and adenosine 2'-O-methylribonucleotides, Inoue et
al. (4) used methyl iodide/silver oxide to alkylate ribonucleoside
that were 3'-5'-protected with the Markiewicz disiloxane reagent
(26). The 2'-O-methyladenosine building block was synthesized
in 7 steps starting from the 6-chloropurine nucleoside. In the case
of guanosine, diazomethane was used to monomethylate the
unprotected 2',3'-cis-diol. In alternative procedures developed
by Sproat et al. (6), efficient 2'-O-alkylation of 3'-5'-disiloxane-
protected ribonucleosides was achieved using methyl iodide/
BDDDP. By this method the adenosine amidite was synthesized
in an 8-step procedure starting from the 6-chloropurine
nucleoside, and the guanosine amidite in 12 steps from the
2-amino-6-chloropurine nucleoside. As described recently (9),
these procedures were also adapted for the preparation of 2'-O-
allyl ribonucleoside monomers utilizing allyl bromide/BDDDP
or palladium(O)-catalyzed allylation.
To prepare 2'-O-methyl building blocks, we initially exploited
the preferred alkylation by diazomethane at the 2'-O position to
obtain the properly protected amidites in few steps starting from
the ribonucleosides (27). Separation from 3'-O-methyl isomers
was performed by vacuum-flash-chromatography (VFC, (28)).
A major drawback of diazomethane alkylation, besides the
inherent risks in the use of a toxic and potentially explosive
reagent, is its restriction to the introduction of methyl groups.
In this paper we describe a simple and efficient procedure for
the preparation of 2'-O-methylated or 2'-0-ethylated
ribonucleoside building blocks for oligomer synthesis. Alkylation
of the nucleosides is performed at an early step of the synthesis
using methyl or ethyl iodide. The direct methylation of
unprotected adenosine has already been described (29).
Analogously, we alkylated cytidine without any protective groups,
whereas with uridine or guanosine it was crucial to prevent N3-
or O6-alkylation by protection. The selectivity of this reaction
for the 2'-O position of the purine nucleosides is considerably
higher than that seen using the diazomethane procedure. The ratio
of the 2'-O-isomer to the 3'-O-isomer exceeded 4:1 for all four
nucleosides. Because the alkylation reaction is carried out at an
early stage of the synthesis, the 3'-O-isomers can easily be
separated at subsequent reaction steps. Introduction of 5'- and
base-protecting groups and phosphitylation leads to the formation
of oligonucleotide building blocks in relatively few synthetic
steps. As a result of the simple handling of the alkylating agents,
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the use of cheap and easily accessible reagents, and the few
synthetic steps, these procedures are useful for the preparation
of 2'-O-alkylated nucleotides.
RESULTS AND DISCUSSION
The syntheses of the cytidine and adenosine building blocks
started with the monomethylation of the unprotected
ribonucleosides (Fig. 1).
The methylation of cytosine (1) was performed with methyl
iodide (1.1 equiv.) in DMF after deprotonation with sodium
hydride (1.6 equiv.). The 2'- and 3'-monomethyl isomers showed
almost identical behavior on chromatography and were separated
from small amounts of higher methylated side products by VFC.
Treatment with benzoyl chloride in pyridine after transient
protection (30) of the sugar hydroxyls with TMS chloride, and
desilylation with aqueous-methanolic ammonia gave a mixture
of the N4-benzoylated O-methyl isomers 2a/5a (81:19 as
determined from l'-H and the methoxy signals of the 'H-NMR
spectrum). After reaction with DMTrCl in pyridine the
5'-tritylated products could be separated by VFC to give 25%
(based on 1) of the 2'-isomer 3a and 5% of the 3'-isomer 6a.
In order to characterize the 5'-unprotected isomers, 3a and 6a
were detritylated to give pure 2a and 5a.
The ethylation of 1 was accomplished analogously using sodium
hydride (1 equiv.) and ethyl iodide (20 equiv.) in DMF. After
benzoylation the 2'-O-ethyl product 2b was obtained in pure form
by recrystallization from ethyl acetate in a yield of 24% (based
on 1) and was converted to the dimethoxytritylated product 3b.
The direct alkylation of adenosine 7 was performed in a similar
fashion as already described for the case of methylation (29).
Subsequent treatment of the transiently TMS-protected
monoalkylated products with phenoxyacetic anhydride yielded
after desilylation a mixture of N6-phenoxyacetyl-protected 2'-
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and 3'-0 alkylated isomers 8 and 11. In the case of methylation
a selectivity in the products 8a/lla of 84:16 was obtained; with
ethylation a significantly higher selectivity (8b/llb 91:9) was
found. Treatment of the isomeric mixtures with DMTrCl in
pyridine gave the corresponding tritylated compounds that could
be easily separated into the pure isomers by VFC. Thus, tritylated
2'-Omethyl-N6-(phenoxyacetyl)adenosine 9a was obtained in an
overall yield of 25% (based on 7). The yield of the corresponding
ethylated product 9b was low, mainly as a result of a non-
optimized procedures for the introduction of phenoxyacetyl and
dimethoxytrityl protective groups; the monoethylated products
8b/llb were obtained in about 50%.
Base-protected 2'-0-alkylguanosines were synthesized by
starting from O6-nitrophenylethyl guanosine 13 (Fig. 2), since
alkylation of unprotected, N2-, or N1 and N2-protected
guanosine preferentially occurred at the base moiety (4,31). The
nitrophenylethyl (NPE) protective group (32) was chosen as it
offers also a guanosine O6-protection that is compatible with the
oligonucleotide synthesis (33). Methylation of 13 was performed
with sodium hydride and methyl iodide at low temperature (-50°
to — 15°C) in order to prevent the loss of the NPE group by
elimination. After purification by VFC a crystalline mixture of
the methyl ethers 14a/19a was obtained in 48 % yield with a ratio
of 86:14 according to 'H-NMR analysis. From this mixture the
pure 2'-O-methyl isomer 14a was isolated by recrystallization.
For practical reasons both the pure isomer 14a as well as the
isomeric mixture 14a/19a, obtained from chromatographic
purification of the mother liquors of the recrystallization, were
converted to the phenoxyacetylated compounds 15a/20a. Further
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Figure 1. Syntheses of cytidine and adenosine building blocks. Figure 2. Synthesis of guanosine building block, a, R=methyl; b, R=ethyl.
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treatment with DMTrCl allowed the efficient chromatographic
separation of the 2'-O-methyl isomer 16a from the 3'-O-methyl
isomer 21a. Removal of the NPE group with diazabicyclo(5.4.0)
undec-7-en (DBU) in pyridine, neutralization with acetic acid and
purification by chromatography gave 18a in high yield.
The ethylation of 13 required a higher reaction temperature
(0°C) as compared to the methylation. As a consequence of partial
elimination of the NPE group the yield of 2'-O-isomer 14b was
significantly lower (13%). Conversion to 15b and further to 16b
was accomplished as described for the methylated analogs.
To synthesize 5'-O-tritylated 2'-O-alkyl-uridines 25a and 25b
(Fig. 3), it was necessary to protect the NMactam group from
alkylation, similar to the guanosine synthesis. Therefore the
cyanoethyl group, which has been used for the protection of
thymidine (33), was introduced at N3 by treatment of 5'-O-
tritylated uridine 22 with sodium hydride/acrylonitrile in DMF.
Purification by VFC gave MMTr-protected 23a or DMTr-
protected 23b in a yield of 45% or 55%, respectively. To prevent
elimination of the cyanoethyl group during the methylation
procedure, deprotonation of 23a was performed with limiting
amounts of sodium hydride (0.9 equiv.) at low temperature
(-40°C), and upon addition of methyl iodide (1.9 equiv.) the
reaction was allowed to warm up slowly to room temperature.
The resulting 2'-O- and 3'-O-methyl isomers 24a and 27a could
be easily separated by chromatography. The ratio of isomers
24a/27a, as determined by yield, was about 81:19. As a side
product dimethylated uridine 28a was isolated. Deprotection of
24a with potassium tert.-butylate gave 5'-O-MMTr-2'-O-
methyluridine 25a. The compound was further characterized by
detritylation to 2'-O-methyl uridine 29a. The ethylation of 23b
afforded 24b/27b in an isomeric ratio of 83:17. Deprotection
of 24b from the cyanoethyl group gave 5'-O-DMTr-2'-O-ethyl
uridine 25b.
Phosphitylation of the protected alkylated nucleosides was
accomplished as described (35) with a modified workup
procedure (Table 1). The carefully dried precursor nucleoside
was treated with (2-cyanoethoxy)-N,N-diisopropylaminochloro-
phosphine and diisopropylethylamine in THF. To avoid chro-
matographic purification, which in the case of the guanosine
compound resulted in partial cleavage of the phenoxyacetyl
protecting group, the reaction was quenched with an lipophilic
secondary alcohol (iso-propanol or sec-butanol). Thus the excess
of phosphitylating agent is converted to a highly soluble amidite
which was easily removed by precipitation of the nucleoside
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Figure3. Synthesis of uridine building block, a, R=methyl, T=MMTr; b, R=ethyl, T=DMTr.
Table 1. Phosphitylation of protected 2'-O-methyl and 2'-O-ethylribonucleosides. TLC solvents: A, acetone/DCM 3:7; E, ethylacetate; D, DCM/ethylacetate 1:1.
To avoid decomposition, TLC was developed without delay (less than 30 sec) after spotting the sample onto the plate.
2'-OCH3 C
2'-OCH3 C
2'-0Et C
2'-OCH3 A
2-OEt A
2'-OCH3 G N P E
2'-OEt G N P E
2'-OCH3 G
2'-OCH3 U
2'-OEt U
DMTr
MMTr
DMTr
DMTr
DMTr
DMTr
DMTr
DMTr
MMTr
DMTr
No.
4a
4a '
4b
10a
10b
17a
17b
18a'
26a
26b
mmol
nucleo-
tide
5.12
3.16
2.95
1.30
0.68
0.28
1.12
1.28
1.30
2.61
amine
equiv.
2
3
3
3
2
2
3
3.6
3
3
chloro-
amidite
equiv.
1.4
1.2
1.6
1.5
1.5
1.4
2.1
2.4
1.5
1.6
alcohol
for
quenching
MeOH
i-PrOH
s-BuOH
i-PrOH
i-PrOH
MeOH
s-BuOH
i-PrOH
i-PrOH
s-BuOH
yield
94%
71%
96%
93%
66%
92%
93%
96%
88%
97%
31
con-
tent
n.d.
3%
7%
1%
2%
n.d.
2%
2%
3%
2%
1H-NMR
1'-H
5.92/5.90
5.92
5.89
6.11
6.10
6.10
6.02
5.94
5.87
5.85/5.83
OMe
3.60
3.57
-
3.46/3.44
-
3.50
-
3.44/3.42
3.50/3.48
-
31P-NMR
149.78/149.09
149.75/149.05
149.64/148.77
149.88/149.57
149.71/149.32
n.d.
149.71/149.49
149.97/149.86
149.75/149.41
149.57/149.18
E
D
D
D
D
A
D
E
Rf
n.d.
O.69/0.55
0.51/0.61
0.63/0.56
0.74/0.81
n.d.
0.87
0.5
0.76/0.70
0.83
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amidite in petroleum ether. A small amount of N,N-diisopropyl-
amino-O-cyanoethyl-H-phosphonate 31, a hydrolysis product of
the phosphitylating agent, coprecipitated with the amidite but did
not cause any detectable decrease in subsequent coupling
efficiency. The protected 2'-O-methyl- and 2'-0-ethylribonucleo-
side-3'-O-phosphoramidites have been successfully used for
oligomer assembly (16). Employing standard methodology with
an increased coupling time of 5 minutes, average coupling
efficiencies of greater than 98% were obtained.
EXPERIMENTAL SECTION
Abbreviations: BDDDP, 2-tert.-butylimino-2-diethyl-amino-
l,3-dimethylperhydro-l,3,2-diazaphosphorin; DCM, dichloro-
methane; DMF, dimethylformamide; DMTr, dimethoxytrityl;
DMTrCl, dimethoxytrityl chloride; LC, column chromatography;
MMTr, monomethoxytrityl; NPE, 2-(4-nitrophenyl)ethyl;
PhOAc, Phenoxyacetyl; RT, room temperature; TLC, thin layer
chromatography; THF, tetrahydrofuran; TMS, trimethylsilyl;
VFC, vacuum flash chromatography;
Ribonucleosides were obtained from Fluka (Switzerland) and
dried (80°C/10-2 mbar / 20 hours) before use. Preparative
liquid chromatography [LC, VFC (28)] and thin layer
chromatography (TLC) were performed on Kieselgel 60 (Merck).
LC and TLC of 5'-O-protected nucleosides were performed using
solvents containing no stabilizing bases like pyridine or
triethylamine, as the crude products still contained significant
amounts of pyridine. The separations were completed within
15—30 min, and better separation properties were observed in
the absence of additional bases. The purified trityl compounds
may be stored in the presence of stabilizing amounts of
triethylamine. NMR spectroscopy ('H,13C,3IP) was performed
on a JEOL FX90Q, a Bruker AC-200, and a Bruker AC-250
spectrometer with variable temperature unit and QNP probehead;
characteristic 'H and 13C signals of described compounds are
shown in Table 2.
N4-Benzoyl-5'-O-dimethoxytrityl-2-O-methylcytidine 3a
A solution containing 40 g (0.164 mol) of cytidine in 650 ml
of dry DMF was treated with 4.33 g (0.18 mol) sodium hydride
for 45 min at 0°C. During a period of 4 hours 36.9 g (0.26 mol)
methyl iodide as a 20% (w/v) solution in DMF was added in
several portions and the reaction mixture was then allowed to
warm up to RT. As the fraction of dimethylated products started
to increase (after ca. 6 h, according to TLC analysis; DMF of
Table 2. >H and I3C NMR of described compounds.
Comp.
2a
2 b
3 a
3 b
5 a
6 a
8a
8b»
9a
9b
1 1 a
11b"
1 2 a
1 4 a
1 4 b
1 5 a
1 5 b
1 6 a
1 6 b
1 8 a
21a
2 3 a
2 3 b
2 4 a
2 5 a
2 5 b
2 7 a
2 8 a
2 9 a
R
2'-OMe
2'-OEt
2'-OMe
2'-OEt
3'-OMe
3'-OMe
2'-OMe
2'-OEt
2'-OMe
2"-OEt
3'-OMe
3'-OEt
3--OM8
2"-OMe
2'-OEt
2'-OMe
3'-OEt
2'-OMe
2'-OEt
2'-OMe
3'-OMe
^ • - O H
^ ' - O H
2'-OMe
2'-OMe
2-OEt
3'-OMe
2",31-
OMe
2'OMe
r
5.83
5.87
6.02
5.84
5.76
5.98
5.95
6.10
6.20
6.15
5.82
5.90
6.04
5.75
5.75
5.92
5.90
6.05
6.00
6.02
5.87
5.92
5.92
6.00
5.97
5.80
5.91
5.95
6.00
2'
3.87
-
-
-
4.33
4.47
-
-
-
-
5.02
-
4 .9
4.65
-
4.65
4.88
4.37
-
-
4.94
-
-
3.95
3.8
4.30*
-
-
4.25
1H-NMR
3'
4.12
-
-
-
-
4.02
-
-
-
-
4.1*
-
-
4.55
4.49
4.65
4.65
4.57
-
4.48
4.29*
-
4.48
4.5*
3.94*
4.03
-
-
4"
3.98
-
-
4.08
4.31
4.3
4.40
4.25
4.11
4.36*
-
-
4.32
4.33
4.3
4.30
4.20
4 .0
-
4.03*
-
-
4.08
4.0*
3.94*
-
-
-
5'
3.9-3.7
-
-
3.9-3.6
3.6-3.4
4.1-3.6
-
3.52
-
4.02/3.74
-
3.6-3.3
3.95/3.74
4.1-3.9
4.02/3.84
4.02/3.84
3.48
-
3.44
-
3.51
3.50
3.60
3.56
-
3.5
3.5
3.74
OCH3
3.48
-
3.70
-
3.34
3.44
3.45
-
3.56
-
3.54
-
3.50
3.35
-
3.39
-
3.63
-
3.49
3.50
-
-
3.75
3.65
.
3.44
3.66
3.46
3.30
r
88.78
87.56
87.99
90.06
91.31
92.24
88.53
88.60
86.41
87.99
91.80
.
89.27
88.42
88.54
88.55
86.19
86.95
85.47
90.40
90.43
90.41
87.18
86.88
87.39
90.13
88.25
86.15
2'
83.38
80.97
83.51
82.74
72.24
73.92
82.80
82.81
82.68
81.76
73.52
.
73.59
82.11
82.44
82.43
83.07
76.36
83.85
75.29
75.26
75.24
83.82
83.80
82.44
73.35
80.69
82.90
13C-NMR
3"
67.11
65.89
67.42
68.66
77.01
78.01
69.73
69.75
69.35
70.47
80.79
-
79.97
70.36
69.85
69.87
69.35
81.54
69.96
81.21
69.84
69.82
68.11
68.15
69.50
78.27
76.36
68.43
4*
84.55
82.88
82.46
83.49
82.54
81.50
87.40
87.44
83.75
84.81
84.57
-
81.89
87.10
87.11
87.13
83.57
84.01
84.15
83.47
83.66
83.66
83.01
82.82
83.87
80.70
81.75
85.33
51
58.96
57.95
60.58
62.01
59.46
61.64
62.30
63.01
62.69
64.03
63.34
-
63.12
63.01
62.47
62.42
62.79
63.22
63.30
63.51
62.09
62.09
61.06
61.07
62.96
61.98
60.83
60.57
OR
58.09
64.55
58.22
67.00
57.38
58.27
58.30
67.60
58.24
67.20
58.00
-
58.13
65.38
58.63
67.61
58.50
66.91
58.85
58.45
-
58.52
58.43
67.01
57.96
58.31
58.07
57.60
13.98
-
15.45
-
-
-
15.45
-
15.38
-
-
-
15.04
-
15.18
-
15.20
-
-
-
-
-
-
15.41
-
-
-
Chemical shifts [ppm] of characteristic signals; full NMR-spectroscopic data are available from the authors upon request; a: determined from a mixture 8b/llb.
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a TLC sample was removed in high vacuum at RT) the reaction
mixture was filtered from precipitated sodium iodide and
evaporated in vacuo. LC of the residue (chloroform/methanol
5:1) gave 22.2 g of a crude mixture of 2'- and 3'-O-methyl-
cytidine (still containing some sodium iodide; TLC:
chloroform/methanol 3:2., Rf=0.3 for both isomers). After
coevaporation with benzene/pyridine 20.8 g of the product
mixture were dissolved in 250 ml of dry pyridine and treated
with 34.9 g (0.32 mol) of trimethylchlorosilane for 1 hour at
RT. After addition of 13.5 g (0.096 mol) of benzoyl chloride
the reaction was kept at RT overnight. The mixture was poured
onto 300 ml water, diluted with 300 ml of methanol and then
250 ml of 25% aqueous ammonia was added. After 20 min the
solution was extracted with DCM several times. The combined
organic phases after drying with sodium sulfate, filtration and
evaporation gave 32 g of a mixture containing 2a/5a (ratio 81:19;
TLC: DCM/methanol 10/1, Rf=0.2, for both isomers). This
mixture, after coevaporation with benzene/pyridine was dissolved
in dry pyridine and treated with 33 g (0.0976 mol) of
dimethoxytrityl chloride for 2 hours at RT. The mixture was
concentrated in vacuo and partitioned between DCM and aqueous
sodium bicarbonate. The aqueous phase was extracted with DCM
several times; the combined DCM extracts were dried with
sodium sulfate and evaporated. LC of the residue (still containing
small amounts of pyridine; 1200 g silica gel, eluent: DCM, then
DCM/acetone 8:1) yielded 25.3 g (25%) 3a and 5.1 g (5%) 6a
as slightly yellow solids (TLC: DCM/acetone 7:3, Rf=0.28 for
3a, Rf=0.24 for 6a).
N4-Benzoyl-2 '-O-methylcytidine 2a: was obtained in pure form
by detritylation of 3a [2% trichloroacetic acid in DCM, 5
min/RT] followed by extraction with water, evaporation of
aqueous phase and purification of the residue by LC
(DCM/acetone first 4:1, then 3:2), 94% yield]. 2a: white
foam;TLC: DCM/acetone 1:1, Rf=0.32.
N4-Benzoyl-3'-O-methylcytidine 5a was characterized as the
product obtained by detritylation of 6a [2% hydrochloric acid
in DCM/ether (50/1); purification by LC (DCM/acetone 2:1),
precipitation from ethylacetate/methanol; 90% yield]. 5a: white
foam;TLC: DCM/acetone 1:1, Rf=0.43.
N4-Benzoyl-2'-O-ethylcytidine 2b
Compound 2b was obtained as described for 3a except that 45
g (0.185 mol) of cytidine was treated with 0.185 mol of sodium
hydride and 40.52 g (3.825 mol) of ethyl iodide. LC purification
gave 25.5 g of isomeric mixture containing monoethylated
products as colorless foam. Subsequent reaction with 32.8 g
(0.301 mol) of trimethylchlorosilane and 19.8 g (0.140 mol) of
benzoyl chloride gave a crude product which after crystallization
from ethylacetate and drying yielded 16.6 g (24 %) pure 2b with
a melting point of 193-194°C. TLC: DCM/isopropanol 9/1,
Rf=0.34.
N4-Benzoyl-5'-0-dimethoxytrityl-2'-0-ethylcytidine 3b
A solution containing 7.30 g (19.4 mmol) of 2b in dry pyridine
was treated with 9.88 g (29.2 mmol) of dimethoxytrityl chloride
and worked up according to the tritylation procedure for 3a.
Purification by LC (DCM/isopropanol 30:1) gave 7.43 g (56.6%)
of pure 3b as a pale yellow solid. TLC: DCM/isopropanol 9/1,
Rf=0.55.
5'-O-Dimethoxytrityl-2'-O-methyl-N6-(phenoxyacetyl)
adenosine 9a
A solution containing 50 g (0.187 mol) of adenosine in 700 ml
of dry DMF was cooled to 0°C and treated with 5.34 g (0.224
mol) of sodium hydride for 45 min at 0°C. During a period of
4 hours 42.2 g (0.30 mol) of methyl iodide as a 20% (w/v)
solution in DMF, was added in several portions the reaction
mixture was then allowed to warm up to RT. As the fraction
of dimethylated products started to increase (according to TLC
analysis; DMF of a TLC sample was removed in high vacuum
at RT) the reaction mixture was filtered from precipitated sodium
iodide and evaporated in vacuo. VFC of the residue
(chloroform/methanol gradient 19:1 to 5:1) gave 42 g of a crude
mixture of 2'- and 3'-O-methyl-adenosine (still containing some
sodium iodide; TLC: chloroform/ethanol 3:1, Rf=0.3 for both
isomers). After coevaporation with benzene/pyridine the product
mixture was dissolved in 500 ml of dry pyridine and treated with
64.8 g (0.60 mol) of trimethylchlorosilane for 2 hours at RT.
After addition of 51.2 g (0.179 mol) of phenoxyacetic anhydride
the reaction was kept at RT overnight. The mixture was poured
into 1000 ml of water and diluted with 400 ml of methanol. After
40 min about 25 g of solid sodium bicarbonate was added to the
resulting clear solution, the mixture was stirred for a further 10
min and was then extracted with DCM several times. The
combined organic phases were dried with sodium sulfate, filtered
and evaporated in vacuo. After coevaporation with
pyridine/benzene the crude product 8a/lla (45 g, ratio 86:14)
was dissolved in dry pyridine and treated with 53.2 g (0.157 mol)
of dimethoxytrityl chloride for 2 hours at RT. The mixture was
concentrated in vacuo and partitioned between DCM and aqueous
sodium bicarbonate. The aqueous phase was extracted with DCM
several times; the combined DCM extracts were dried with
sodium sulfate and evaporated in vacuo. VFC of the residue
(DCM then DCM/acetone 8:1) yielded 32.8 g (25 %) of 9a and
3.3 g (2.5%) of 12a as colorless solids (TLC: DCM/acetone 7:3,
9a: Rf=0.52,12a: Rf=0.48).
2'-O-Methyl-N6-(phenoxyacetyl)adenosine 8a: The crude
product containing 8a/lla, obtained according to the procedure
given above, was purified by LC (400 g silica gel; DCM/acetone
4:1) to give 5.5 g (7.05% based on 7) of 8a, with given analytical
data, and 14.1 g (18.1% based on 7) of mixture of 8a/lla (TLC:
DCM/methanol = 9:1, 8a: Rf=0.50; l la: Rf=0.48).
3'-0-Methyl-N6-(phenoxyacetyl)adenosine l la was characterized
as the product obtained by detritylation of 12a [2% hydrochloric
acid in DCM/ether (50:1), -5°C for 1 min; purification by VFC
(DCM/acetone 3.5:1), 92% yield], l la: white foam;TLC:
DCM/methanol 9:1, Rf=0.48.
5'-O-Dimethoxytrityl-2'-O-ethyl-N6-(phenoxyacetyl)
adenosine 9b
Compound 9b was synthesized according to the procedure used
for preparation of 9a, except that 50 g (187 mmol) of adenosine
was treated with 5.40 g (225 mmol) sodium hydride and 81.3
g (525 mmol) of ethyl iodide for 4 hours at 0°C. The following
LC purification gave 30 g of isomeric mixture containing
monoethylated products as colorless foam. Subsequent reaction
with 44.1 g (406 mmol) of trimethylchlorosilane and 58.4 g (203
mmol) of phenoxyacetic anhydride gave a crude product which
upon partial purification by VFC (DCM/THF 1:1) and drying
in vacuo gave 19.7 g (25%) of a mixture containing 8b/llb (ratio
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10:1) as colorless foam. Tritylation of 19.6 g of 8b/llb in 100
ml of dry pyridine with 23.2 g (69 mmol) of dimethoxytrityl
chloride, as described for 9a, and VFC purification (DCM/THF
gradient from 12:1 to 6:1) gave4.8 g of 9b (3.5% overall yield
from adenosine) as white foam. 9b: TLC: DCM/isopropanol
16/1, Rf=0.42. ( 3'-regioisomer 12b,not isolated, Rf=0.46).
2'-O-Ethyl-(phenoxyacetyl)adenosine 8b: TLC: DCM/
isopropanol 9/1, Rf=0.34.
2'-0-Methyl-06-[2-(4-nitrophenyl)ethyl]guanosine 14a
After coevaporation with DMF/benzene 8.1 g 13 (32) was
dissolved in 130 ml of dry DMF and treated with 1.6 equiv. of
sodium hydride for 45 min at — 50°C. During a 5 h period 8
equiv. of methyl iodide was added and the reaction mixture
allowed to warm up to — 15°C. Ammonium chloride was then
added and the mixture was evaporated in vacuo. The resulting
residue was purified by VLC (chlorofoim/methanol 80:1) to yield
4.0 g (48%) of a mixture containing 14a/19a (86:14). 1.8 g (22%)
of colorless crystals (Fp. = 109 -111°C, NMR) of pure 14a (less
than 1% 19a) was obtained by recrystallization from
benzene/chloroform. The mother liquor was evaporated and
purified by LC (DCM/isopropanol 30:1) to give 1.7 g (20.4%)
crystals containing a mixture of 14a/19a (82:18). TLC:
DCM/isopropanol 5:1, Rf=0.56 (14a), Rf=0.61 (19a).
2'-0-Ethyl-06-[2-(4-nitrophenyl)ethyl]guanosine 14b
A solution containing 3.15 g of dry 13 (32) in 30 ml DMF was
treated with 0.9 equiv. of sodium hydride at -15°C for 1 h.
Then 8 equiv. of ethyl iodide was added during a period of 2
h at — 15°C and the solution was subsequently stirred at 0°C
for 3 h. The workup was performed as described for 14a, with
0.44 g (13%) of white foam 14b being obtained by LC
(DCM/isopropanol 16:1). TLC: DCM/isopropanol 9:1,
Rf=0.37 (14b), Rf=0.46 (3'-regioisomer 19b, not isolated).
2'-0-Methyl-06-[2-(4-nitrophenyl)ethyl]-N2-(phenoxyacetyl)
guanosine 15a
After drying by coevaporation with pyridine/benzene, 1.5 g of
14a was dissolved in 150 ml of pyridine and 5 equiv. of
trimethylchlorosilane added at RT over a duration of 30 min.
After 2 h 1.4 equiv. of phenoxyacetic anhydride was added at
RT and the reaction mixture stirred over night. The reaction was
then quenched by addition of 250 ml of aqueous methanol (50%)
and 10 ml of cone, aqueous ammonia, after 10 min the product
was extracted with DCM. Following drying (sodium sulfate) of
the combined DCM phases and evaporation in vacuo, 1.85 g of
colorless foam 15a was obtained (NMR). Analogously 1.7 g of
a mixture of 14a/19a (82:18) was phenoxyacetylated to give 1.8
g (81%) of a mixture of the two isomers 15a/20a. TLC:
chloroform/methanol 15:1, Rf=0.36 (15a), Rf=0.38 (20a).
2'-0-Ethyl-06-[2-(4-nitrophenyl)ethyl]-N2-(phenoxyacetyl)
guanosine 15b
Phenoxyacetylation of 0.44 g of 14b was accomplished as
described for 15a. The crude product was purified by LC
(DCM/isopropanol 10:1) to yield 0.47 g (82%) of 15b as
colorless foam. TLC: DCM/isopropanol 9:1, Rf=0.45.
5 ' -O-Dimethoxytrityl-2' -O-methyI-O6-[2- (4-nitrophenyl)
ethyl]-N2-(phenoxyacetyl)guanosine 16a
Compound 15a (3.0 g of a mixture containing 0.3 g of
regioisomer 20a) was dried by coevaporation with
benzene/pyridine and dissolved in 350 ml of pyridine. After
addition of 1.2 equiv. of dimethoxytrityl chloride the solution
was stirred for 2 h at RT and then evaporated in vacuo. The
residue was taken up in aqueous bicarbonate and extracted with
DCM. The combined organic phases were dried (sodium sulfate),
filtered and evaporated in vacuo. The residue was separated by
LC (toluene/isopropanol 30:1) to give 4.1 g (81%) of 16a and
0.3 g (6%) of 21a as pale yellow foams. TLC:
toluene/isopropanol 9:1, Rf=0.24 (16a), Rf=0.28 (21a).
5-0-DimethoxytrityI-2'-0-ethyl-06-[2-(4-nitrophenyl)ethyl-
]-N2-(phenoxyacetyl)guanosine 16b
Compound 16b was prepared from 0.47 g of 15b according to
the procedure given for 16a. LC purification (DCM/acetone 15:1)
of the crude product gave 483 mg (68%) of pure 16b as a yellow
powder. TLC: DCM/isopropanol 9:1, Rf=0.60.
5'-O-Dimethoxytrityl-2'-O-methyl-N2-(phenoxyacetyl)
guanosine 18a
A solution containing 150 mg of 16a in 5 ml of a 0.5 M
l,8-diazabicyclo(5.4.0)undec-7-ene (DBU) in pyridine was stirred
for 2 h at RT. Then 1.5 ml of 1 M aqueous acetic acid was added
slowly, the mixture diluted with water and the aqueous phase
extracted with DCM. The combined organic phases were dried
(sodium sulfate) and evaporated in vacuo. VFC of the residue
(DCM/acetone/triethylamine 100:10:2) gave 95 mg (76%) of 18a
as a colorless oil. TLC: Chloroform/Methanol=4.8/0.3,
Rf=0.38.
N3-(2-Cyanoethyl)-5'-O-monomethoxytrityIuridine 23a
After coevaporation with DMF/benzene 7 g of 22a (prepared
according to published procedures(34)) was dissolved in 100 ml
of dry DMF, cooled to 0°C and treated with 1 equiv. of sodium
hydride for 1 h. During 12 h 20 equiv. of acrylonitrile were added
and the reaction mixture heated to 80°C. The reaction was then
quenched by pouring onto water/DCM. The crude product
obtained by evaporation of the DCM extract was purified by VFC
(DCM/acetone 30:1) to yield 3.5 g (45%) of colorless foam 23a.
TLC: DCM/acetone = 33:2, Rf=0.42.
N3-(2-Cyanoethyl)-5'-O-dimethoxytrityluridine 23b
Compound 23b (24.0 g) was obtained analogously to 23a from
40 g of 22b (prepared according to published procedures(34))
in 55% yield as colorless solid. 23b: TLC: DCM/isopropanol
9:1, Rf=0.51.
N3-(2-Cyanoethyl)-2'-O-methyl-5'-O-monomethoxytrityl-
uridine 24a
A solution containing 600 mg of 23a in 10 ml dry DMF was
cooled to -40°C and treated with 0.9 equiv. of NaH for 45 min.
Then 1.9 equiv. methyl iodide was added and during a period
of 3 h the temperature raised to RT. The reaction was quenched
by addition of ammonium chloride and evaporated. The residue
was dissolved in water and extracted with DCM. After drying
(sodium sulfate) and evaporation of the combined organic phases
in vacuo, the reaction products were separated by LC (ether) to
give 200 mg (33%) of 24a, 48 mg (8%) of 3'-O-methyl product
27a and 80 mg (13%) of dimethylated product 28a as colorless
foams. TLC: DCM/acetone=3.2:1.8, Rf=0.80 (24a), Rf=0.74
(27a), Rf=0.87 (28a).
2'-0-Methyl-5'-0-monomethoxytrityIuridine 25a
A solution containing 100 mg of 24a in DCM was treated with
2 equiv. of KOt-Bu for 30 min and then poured onto aqueous
sodium bicarbonate. After extraction with DCM the organic phase
was dried (sodium sulfate) evaporated in vacuo and the crude
product purified by VFC (DCM/acetone 9:1) to yield 80 mg
(85%) of 25a as a colorless solid. TLC: DCM/acetone=3:2,
Rf=0.41.
5'-O-Dimethoxytrityl-2'-O-ethyluridine 25b
A DMF solution containing 32.4 g of 23b was treated with 1
equiv. of NaH for 1 h at -45°C. Then 1.6 equiv. of ethyl iodide
was added and the temperature raised to RT during a period of
3 h. After workup and chromatography as described for 24a 8.1
g of 2'-O-ethyl isomer 24b and 1.6 g 3'-O-ethyl isomer 27b were
obtained. The N3-deprotection of 24b (as described for 25a) and
purification by LC (DCM/acetone 12:1) gave 6.6 g (20% calc.
from 23b) of an off-white foam 25b. TLC: DCM/isopropanol
9:1, Rf=0.63.
2-O-Methyluridine 29a
A solution containing 8 g of 25a in 100 ml of methanol was
treated with 5 ml of 10% methanolic HC1 at RT for 5 min. The
reaction mixture was evaporated in vacuo and die residue
partitioned between ether and water. The organic phase was
washed twice with water and the combined aqueous phases
evaporated in vacuo. The product was dried by evaporation with
benzene and pyridine to give 3.27 g (93%) 29a as colorless foam.
TLC: Dichloromethane/Methanol = 3/1. Rf=0.37.
Phosphitylation
After drying by coevaporation with pyridine, toluene and THF,
1 - 3 mmol of the protected nucleoside 3a, 3a' (1), 3b, 9a, 9b,
16a, 16b, 18a, 25a or 25b was dissolved in 25 ml THF (in the
case of 3a, 16a dry DCM was used) and 2 -3 .6 equiv. of N,N-
diisopropylethylamine (Hiinig's base) added under nitrogen. 1.2
to 2.4 equiv. of (2-cyanoethoxy)-N,N-diisopropylaminochloro-
phosphine was subsequently added during a period of 5 min at
RT. The reaction was then stirred for 2 h and monitored by TLC
(the phosphoramidite gives a yellow color with ninhydrin
reagent). If starting material was still present an additional 0.3
equiv. of phosphitylation agent was added. Any excess reagent
was quenched by the addition of 3 —5 equiv. of isopropanol (sec-
butanol or methanol) and stirred for an additional hour. Then
the solvent was partially removed by evaporation in vacuo and
degased ethylacetate (50 ml) added. The solution was extracted
twice with degased 1 M aqueous sodium bicarbonate (100 ml)
under argon at 0°C, dried with sodium sulfate and evaporated.
The residue was coevaporated twice with toluene and dissolved
in 3 - 5 ml of degased toluene (pyrimidines) or ethylacetate
(purines). The solution was added dropwise to 200 ml dry
petroleum ether (bp. 40-60°C) and the colorless precipitate
collected by filtration under nitrogen. After thorough washing
with hexane, the phosphoramidite was dried in vacuo and
dissolved in dry acetonitrile to give a 100 mM solution which
was directly used for oligonucleotide synthesis. The content of
die coprecipitated cyanoethyl-N,N-diisopropyl H-phosphonate 31
was judged by 'H and 3IP-NMR and did not affect coupling
efficiency (Table 1). The solution was stored at -20°C over
3 ii molecular sieve and could be kept for several months without
detectable decomposition.
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